The size of the North American blood flow measurement devices market is forecasted to grow USD 323.12 million by 2028 from USD 206.20 million in 2023, registering a CAGR of 9.4% between 2023 to 2028.
The diabetic epidemic, along with rising cases of cardiovascular diseases, an influx of VC funding, augmenting the geriatric population, and technological advancements are the factors fuelling the growth of this market.
Increasing usage of these devices in chronic disease treatments, majorly in heart-related disorders, and growing demand for minimally invasive surgeries accelerates the market demand in the North American region. An estimated 2 out of every 5 Americans have diabetes as per National Diabetes Statistics Report, 2017. Technological advancements in this field are another significant factor contributing to the growth of the market. Growing healthcare expenditure and increasing enrollments in blood flow monitors are further expected to favor the blood flow measurement devices market in North America. Secondary driving factors include the rising number of organ transplants and technological advancements.
Strict regulatory frameworks and cumbersome bureaucratic procedures are the primary inhibitors of the market. Costs associated with these days are not affordable to everybody in the countries of North American countries, which is projected to show a little negative impact on the market.
This research report on the North American Blood Flow Measurement Devices Market has been segmented and sub-segmented into the following categories:
Regionally, North America accounted for the largest share in the North American blood flow measurement devices market and registered a 40% share in the global market in 2022. The United States is the leading player in this region. The rising geriatric population, increased prevalence of hypertension, increased funding, and the majority of cardiovascular diseases are some of the factors that are attributable to the observable trend mentioned above.
U.S and Canada are the two countries accounting significant share in the North American blood flow measurement devices market. The United States is dominating the North American market with the highest share due to inactive lifestyles and an upsurge in the number of people diagnosed with diabetes. Technological advancements in identifying different kinds of diseases may provide profitable opportunities, and these blood flow measurement devices assist in early diagnosis, which analyzes the treatment techniques.
The U.S follows Canada in leading the market due to the increasing number of clinical applications for invasive and non-invasive processes.
Promising Companies dominating the North America Blood Flow Measurements Devices Market Profiled in the Report are Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Perimed AB (Sweden), Medistim ASA (Norway), ADInstruments (Australia), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Moor Instruments Ltd. (U.K.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com